PDS Biotechnology (PDSB) Enterprise Value (2015 - 2026)
PDS Biotechnology (PDSB) posted Enterprise Value of $43.61 million for Q2 2026, up 44.8% from $30.12 million a year earlier.
Powered by 
Analysis
PDS Biotechnology (PDSB) Enterprise Value (2015 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Enterprise Value at PDS Biotechnology was -$41.2 million; for FY2025, it came in at $15.54 million, down 23.2% from FY2024.
- Annual Enterprise Value has declined for three consecutive years, though with a five-year compound annual growth rate of 17.3% (FY2020 to FY2025).
- In prior years, PDS Biotechnology's Enterprise Value was $20.23 million in FY2024 (-81.3%), $107.92 million in FY2023 (-66.7%), $324.43 million in FY2022 (+96.4%) and $165.19 million in FY2021.
- The Q2 2026 figure stands as the highest quarterly Enterprise Value since Q3 2024.
- On a year-over-year basis, Enterprise Value increased in 1 of the last seven quarters, with an average decline of 38.4%.
- The strongest year-over-year quarter for Enterprise Value in the past five years was Q3 2023, with growth of 694.2%; the weakest was Q3 2022, with a decline of 96.4%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | PDS Biotechnology | 43.06 Mn | 43.06 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 43.61 Mn |
| Dec 31, 2025 | 15.54 Mn |
| Sep 30, 2025 | 21.98 Mn |
| Jun 30, 2025 | 30.12 Mn |
| Mar 31, 2025 | 14.08 Mn |
| Dec 31, 2024 | 20.23 Mn |
| Sep 30, 2024 | 90.85 Mn |
| Jun 30, 2024 | 50.03 Mn |
| Mar 31, 2024 | 78.62 Mn |
| Dec 31, 2023 | 107.92 Mn |
| Sep 30, 2023 | 102.29 Mn |
| Jun 30, 2023 | 94.64 Mn |
| Mar 31, 2023 | 123.75 Mn |
| Dec 31, 2022 | 324.43 Mn |
| Sep 30, 2022 | 12.88 Mn |
| Jun 30, 2022 | 50.87 Mn |
| Mar 31, 2022 | 117.21 Mn |
| Dec 31, 2021 | 165.19 Mn |
| Sep 30, 2021 | 353.94 Mn |
| Jun 30, 2021 | 215.91 Mn |
API Access
PDS Biotechnology Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=PDSB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "PDSB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=PDSB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();